Trajectory of certain death at an unknown time: children with neurodegenerative life-threatening illnesses

R G Steele1

  • 1School of Nursing, York University, Toronto, Ontario, Canada. rose.steele@sympatico.ca

Insights

Families caring for children with neurodegenerative life-threatening illnesses at home navigate unpredictable illness trajectories. They experience isolation during stable periods and face challenges during inevitable declines toward the child's death.

Area of Science:

  • Palliative Care
  • Pediatric Oncology
  • Family Studies

Background:

  • Neurodegenerative life-threatening illnesses (NLTIs) represent a significant burden for children requiring palliative care.
  • Most pediatric palliative care occurs at home, predominantly managed by families over extended periods.
  • There is limited research on the experiences of families caring for a dying child with an NLTI at home.

Purpose of the Study:

  • To explore the lived experiences of families navigating the dying process of a child with an NLTI at home.
  • To understand the challenges and support needs of these families.

Main Methods:

  • Grounded theory approach utilized.
  • Data collected through observations and audiotaped interviews with 8 families.
  • Analysis focused on identifying recurring themes and processes.

Main Results:

  • Families described navigating 'uncharted territory' with a dying child.
  • Illness trajectories were not linear, characterized by plateaus of stability and periods of acute instability.
  • Families reported feelings of isolation from healthcare professionals during stable phases.

Conclusions:

  • The study highlights the complex, non-linear nature of pediatric palliative care at home for children with NLTIs.
  • Findings underscore the need for improved support systems and communication for families during both stable and unstable phases of illness.
  • Implications for clinical practice and future research are discussed to better assist families in this challenging journey.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...